Predicting resectability with ct prediction of resectability

Predicting resectability with ct prediction of resectability
depends on correct detection of t4, n3, and/or
m1 tumors. one prospective study of ninety six patients with lung
cancer and preoperative ct found a 12% prevalence of unresectability.
212 ct criteria for unresectability included encasement
of the proximal pulmonary arteries or carina, or gross
mediastinal involvement by tumor, or widespread lymphadenopathy
or distant metastases. using these criteria, ct was
96% correct and showed 97% ppv and 50% npv for resectability.
another, additional recent study found that ct erred in
predicting resectability in twelve of 50 patients ( 24% ). 213 in three
patients, a malignant pleural effusion was missed at ct, and that in
9 patients, operable patients were deemed inoperable at ct
because of incorrect diagnosis of malignant pleural effusion ( three
patients ) or direct mediastinal tumor invasion ( six patients ).
thus the usefulness of ct during this setting is uncertain.
current usefulness of pretreatment ct it's important
for the radiologist to grasp what treatment choices are available
at his or her explicit institution and what features of the
tumor or its spread would affect treatment choices. at most
establishments, proven t4, n3, or m1 disease is thought of unresectable.
patients with n2 disease is also treated with preoperative
chemotherapy and radiation therapy. ct findings are used
to assist define the extent of the primary nodule or mass, look
for calcifications which may indicate benignancy, verify its
relationships with nearby structures, assess for resectability, and
recommend the kind of operation needed for resection. if enlarged mediastinal
lymph nodes are detected, ct is also used to direct
preoperative lymph node sampling via transbronchoscopic wang
needle biopsy, tee, ebus, mediastinoscopy, mediastinotomy,
or video-assisted thoracoscopic operation ( vats ). nodes accessible
to transbronchoscopic wang needle biopsy embrace the paratracheal,
tracheobronchial, and subcarinal teams. transbronchial
wang needle biopsy is also facilitated by ultrasound steering.
nodes accessible to mediastinoscopy embrace pretracheal, anterior
subcarinal, and anterior tracheobronchial teams. lymph nodes
within the aortopulmonary window don't seem to be accessible using these
techniques, and tissue sampling needs different approaches such
as vats or anterior thoracotomy. as an different to surgical
staging procedures, a few teams advocate the use of ct-guided
hilar and mediastinal lymph node biopsies, 214–216 though this
isn't common follow unless the nodal masses are massive.
in summary, at several establishments, preoperative chest ct,
as well as the adrenal glands, is routinely performed on all patients
suspected of having nsclc. dedicated abdominal ct
isn't typically necessary, given the low frequency of isolated
liver metastases. intravenous contrast material is typically administered
to assist distinguish vessels from lymph nodes and
to aid in analysis of primary tumor extent. though, some
investigators believe that intravenous contrast is unnecessary,
as a result of the added info obtained from the use of contrast
material rarely changes tumor stage and doesn't substantially
influence management choices. 217
several ct studies have reported high npvs in detecting
metastatic disease to mediastinal lymph nodes. additionally,
daly et al. 168 reported that overall projected 2- and 5-year
survival rates for thirty seven ct false-negative patients within their series
were 40% and 28%, respectively. given this info, many
investigators believe that a negative ct obviates the want for
mediastinoscopy, and therefore these patients ought to go directly to thoracotomy.
146, 160, 168 an exception is also created for patients
with t3 tumors or central adenocarcinomas, because of the high
incidence of positive mediastinal lymph nodes and low npv of
ct during this setting. 168 additionally, patients with suspected chest
wall invasion, as well as pancoast tumors, ought to in all probability have
mediastinoscopy regardless of ct findings, as a result of mediastinal
nodal metastases and chest wall invasion portend a poor prognosis,
and therefore these patients don't seem to be sometimes felt to be surgical candidates.
100, 101 in a very dissenting opinion, pearson et al. 218 recommended
mediastinoscopy for all t2 and t3 tumors and for t1
adenocarcinomas and enormous cell carcinomas, even within the setting
of a negative ct. a additional recent study by kernstine et al. 176
took this a step additional, concluding that ct wasn't sensitive
or specific enough to amendment their current recommendation to
perform surgical analysis on behalf of mediastinal lymph node staging
in a veryll patients. on the opposite hand, it's typically agreed
that all patients with abnormal mediastinal lymph nodes at ct
want lymph node biopsy ( or futher imaging with fdg–pet ) ;
therapy shouldn't be planned primarily based on unproven, positive ct
findings. mediastinal and hilar lymph node stations, as delineated
by the ats, are mapped employing axial ct scans in a very
recently printed atlas 219 ; reference to such commonplace locations
is essential in directing correct lymph node sampling.